On January 10, Alvotech announced that the European Commission issued a marketing authorization to its European commercialization partner, STADA, for UZPRUVO , a biosimilar referencing STELARA . The...

Related Keywords

Canada , Liechtenstein , Japan , Norway , Iceland , , European Commission , Pharma Group , European Economic Area , Supplementary Protection Certificate , Big Molecule Watch , Markets ,